Temazepam
Administration
- Type: Benzodiazepine
- Dosage Forms: Cap 7.5mg, 15mg, 22.5mg, 30mg
- Routes of Administration: Oral
- Common Trade Names: Restoril
Adult Dosing
Insomnia
- 15mg PO qhs
- Start 7.5mg PO qhs in elderly patients
Sleep terrors
- 15-30mg PO qhs
Pediatric Dosing
Safety/efficacy not established in pediatric patients
Special Populations
Pregnancy Rating
- Consider alternatives during pregnancy
- Risk of neonatal withdrawal symptoms and floppy infant syndrome
Lactation risk
- May use low doses short-term when breastfeeding
Renal Dosing
- Adult: No adjustment
- Pediatric: Not defined
Hepatic Dosing
- Adult: No adjustment
- Pediatric: Not defined
Contraindications
- Allergy to class/drug
- Pregnancy
- Avoid abrupt withdrawal with long term use
Adverse Reactions
Serious
- Anaphylaxis, angioedema
- Respiratory depression
- Dependency
- Seizure
- Suicidality
- Tachycardia, hypotension, syncope
Common
- Drowsiness, fatigue
- Dizziness
- Anxiety, Amnesia, confusion
- Disinhibition
- Dystonia. Dysarthria, diplopia
- Incontinence, constipation
- Rash
Pharmacology
- Half-life: 8.8h
- Metabolism: Liver
- Excretion: Urine 80-90%
Mechanism of Action
- Binds to benzodiazepine receptors to enhance GABA effects
Comments
See Also
References
This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.